Literature DB >> 1085595

T and B lymphocytes and cutaneous anergy in inflammatory bowel disease.

D B Sachar, R N Taub, K Ramachandar, S Meyers, S P Forman, S D Douglas, H D Janowitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085595     DOI: 10.1111/j.1749-6632.1976.tb47071.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  15 in total

1.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

2.  Influence of SRBC/lymphocyte ratio on T-cell rosettes in alcoholic liver disease and inflammatory bowel disease.

Authors:  M G Mutchnick; D S White; A C Dopp
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

3.  Alteration in T lymphocyte subpopulations in inflammatory bowel disease.

Authors:  R M Victorino; H J Hodgson
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

4.  Immunological abnormalities involving the thymus in ulcerative colitis and therapeutic effects of thymectomy.

Authors:  M Tsuchiya
Journal:  Gastroenterol Jpn       Date:  1984-06

Review 5.  Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?

Authors:  R G Shorter
Journal:  Gastroenterol Jpn       Date:  1982-10

6.  Spontaneous suppressor cell function in inflammatory bowel disease.

Authors:  R M Victorino; H J Hodgson
Journal:  Dig Dis Sci       Date:  1981-09       Impact factor: 3.199

7.  Crohn disease. Newer aspects of etiology, diagnosis and therapy.

Authors: 
Journal:  West J Med       Date:  1978-05

8.  Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes.

Authors:  I O Auer; S Götz; E Ziemer; H Malchow; H Ehms
Journal:  Gut       Date:  1979-04       Impact factor: 23.059

9.  Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies.

Authors:  S Meyers; D B Sachar; R N Taub; H D Janowitz
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

10.  Enumeration of lymphocyte populations defined by surface markers in the whole blood of patients with Crohn's disease.

Authors:  E O Pepys; E A Fagan; G A Tennent; V S Chadwick; M B Pepys
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.